Akèy › Metiyè › Bioengineers and Biomedical Engineers › Seattle, WA
Bioengineers and Biomedical Engineers nan Seattle, WA: Salè H-1B
24 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Seattle, WA. Salè baz medyàn ofri $84,431; mwatye mitan $74,250–$120,968.
Demann (LCA)24
Salè medyan ofri$84,431
Mwatye salè yo$74,250–$120,968
10yèm–90yèm pousantaj$66,856–$158,000
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $78,226 |
| Nivo II (kalifye) | $87,861 |
| Nivo III (eksperyans) | $125,000 |
| Nivo IV (plen kompetans) | $170,000 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| University of Washington | 8 | $71,706 |
| Allen Institute | 3 | $82,742 |
| Keyamed Na Inc | 2 | $120,968 |
| Seattle Children's Hospital | 2 | $75,000 |
| Concord III, LLC | 1 | $222,000 |
| Devote Consulting Inc. | 1 | $170,000 |
| Novo Nordisk Research Center Seattle Inc. | 1 | $81,453 |
| Cartography Biosciences, Inc. | 1 | $130,000 |
| Food and Drug Administration | 1 | $109,546 |
| Key Proteo, Inc. | 1 | $95,722 |
| Becton, Dickinson and Company | 1 | $125,000 |
| InBios International, Inc. | 1 | $75,000 |
| Bristol-Myers Squibb Company | 1 | $294,662 |
Tit travay
- Postdoctoral Scholar6
- Senior Imaging Engineer2
- Invent Fellow - PhD, Research2
- Scientist I2
- Scientific Data Engineer1
- Senior Product Manager1
- Senior Consultant1
- Engineer II1
- Data Scientist1
- Visiting Associate1
- Research Scientist1
- Sr. Quality Engineer1
- Research Scientist/Engineer 41
- Research Scientist/Engineer 21
- Quality Engineer I1
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).